These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 10805381)
1. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis. Gelman IH; Tombler E; Vargas J Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381 [TBL] [Abstract][Full Text] [Related]
2. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS. Gelman IH; Lee K; Tombler E; Gordon R; Lin X Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295 [TBL] [Abstract][Full Text] [Related]
3. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Xia W; Unger P; Miller L; Nelson J; Gelman IH Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719 [TBL] [Abstract][Full Text] [Related]
4. Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. Nelson PJ; Moissoglu K; Vargas J; Klotman PE; Gelman IH J Cell Sci; 1999 Feb; 112 ( Pt 3)():361-70. PubMed ID: 9885289 [TBL] [Abstract][Full Text] [Related]
5. SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression. Coats SR; Covington JW; Su M; Pabón-Peña LM; Eren M; Hao Q; Vaughan DE J Mol Cell Cardiol; 2000 Dec; 32(12):2207-19. PubMed ID: 11112996 [TBL] [Abstract][Full Text] [Related]
6. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response. Nelson PJ; Gelman IH Mol Cell Biochem; 1997 Oct; 175(1-2):233-41. PubMed ID: 9350056 [TBL] [Abstract][Full Text] [Related]
7. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Lin X; Nelson P; Gelman IH Mol Cell Biol; 2000 Oct; 20(19):7259-72. PubMed ID: 10982843 [TBL] [Abstract][Full Text] [Related]
8. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Lin X; Gelman IH Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136 [TBL] [Abstract][Full Text] [Related]
9. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. Su B; Bu Y; Engelberg D; Gelman IH J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890 [TBL] [Abstract][Full Text] [Related]
10. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12. Guo LW; Gao L; Rothschild J; Su B; Gelman IH J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576 [TBL] [Abstract][Full Text] [Related]
11. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12. Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722 [TBL] [Abstract][Full Text] [Related]
12. Induction of Src-suppressed C kinase substrate (SSeCKS) in vascular endothelial cells by bacterial lipopolysaccharide. Kitamura H; Okita K; Fujikura D; Mori K; Iwanaga T; Saito M J Histochem Cytochem; 2002 Feb; 50(2):245-55. PubMed ID: 11799143 [TBL] [Abstract][Full Text] [Related]
13. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. Lin X; Tombler E; Nelson PJ; Ross M; Gelman IH J Biol Chem; 1996 Nov; 271(45):28430-8. PubMed ID: 8910468 [TBL] [Abstract][Full Text] [Related]
14. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development . Gelman IH Front Biosci; 2002 Aug; 7():d1782-97. PubMed ID: 12133808 [TBL] [Abstract][Full Text] [Related]
15. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. Lin X; Gelman IH Biochem Biophys Res Commun; 2002 Feb; 290(5):1368-75. PubMed ID: 11820772 [TBL] [Abstract][Full Text] [Related]
16. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways. Gelman IH; Gao L Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152 [TBL] [Abstract][Full Text] [Related]
17. Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia. Akakura S; Huang C; Nelson PJ; Foster B; Gelman IH Cancer Res; 2008 Jul; 68(13):5096-103. PubMed ID: 18593908 [TBL] [Abstract][Full Text] [Related]
18. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis. Liu Y; Gao L; Gelman IH BMC Cancer; 2006 Apr; 6():105. PubMed ID: 16638134 [TBL] [Abstract][Full Text] [Related]
19. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein. Xia W; Gelman IH Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796 [TBL] [Abstract][Full Text] [Related]
20. Ligand-specific control of src-suppressed C kinase substrate gene expression. Coats SR; Pabón-Peña LM; Covington JW; Vaughan DE Biochem Biophys Res Commun; 2002 Oct; 297(5):1112-20. PubMed ID: 12372401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]